BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16624929)

  • 1. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
    Feldmann M; Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neutrophil cytoplasm-associated glomerulonephritis.
    Morgan MD; Harper L; Williams J; Savage C
    J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
    Wüthrich RP
    Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-neutrophil cytoplasmic autoantibody (ANCA) in systemic vasculitic syndrome].
    Arimura Y; Nagasawa T
    Rinsho Byori; 1993 Aug; 41(8):866-75. PubMed ID: 8371502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
    Heeringa P; Huugen D; Tervaert JW
    Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis.
    Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1221-3. PubMed ID: 16624927
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro.
    Weidner S; Neupert W; Goppelt-Struebe M; Rupprecht HD
    Arthritis Rheum; 2001 Jul; 44(7):1698-706. PubMed ID: 11465722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.